Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. whi https://www.news-medical.net/news/20181016/Eisai-enters-into-agreement-with-Eurofarma-for-development-and-sales-of-lorcaserin-in-17-countries.aspx